Resultados de la búsqueda 281-290 of 9002 for 5-HTP

1. Depresión y ansiedad: ¿puedo tener ambas? - Mayo Clinic

   http://dsm.psychiatryonline.org. Accessed Oct. 1, 2024. Depressive disorders. In: Diagnostic and Statistical Manual of Mental Disorders DSM-5-TR. 5th ed.

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   [5, 6] An ideal adoptive cellular therapy must possess the ability to not only return to the site of the tumor but must also retain cytotoxic potential ...

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   [5, 6] An ideal adoptive cellular therapy must possess the ability to not only return to the site of the tumor but must also retain cytotoxic potential ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Scottsdale/Phoenix, Ariz. This phase II trial tests how well turkey tail mushroom (TTM) works in treating post-menopausal women with HER2-negative, estrogen ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   [5, 6] An ideal adoptive cellular therapy must possess the ability to not only return to the site of the tumor but must also retain cytotoxic potential ...

6. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

   Early diagnosis of nerve root avulsion injuries following brachial plexus trauma remain a barrier to the early treatment of these complex injuries.

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The study will concurrently enroll patients with four distinct advanced malignancies in 5 separate tumor cohorts. The four cancer types are: Non-Small Cell ...

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   [5, 6] An ideal adoptive cellular therapy must possess the ability to not only return to the site of the tumor but must also retain cytotoxic potential ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   [5, 6] An ideal adoptive cellular therapy must possess the ability to not only return to the site of the tumor but must also retain cytotoxic potential ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... (5) advanced, unresectable colorectal cancer, (6) advanced, unresectable ... The primary endpoint is EFS and 774 eligible and evaluable patients are anticipated to ...